v3.26.1
Unaudited Condensed Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024   17,640,328    
Beginning balance at Dec. 31, 2024 $ 9,540 $ 18 $ 303,853 $ (294,331)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of stock from vested restricted stock units (in shares)   229,151    
Issuance of stock under Employee Stock Purchase Plan (in shares)   80,554    
Issuance of stock under Employee Stock Purchase Plan 198   198  
Stock-based compensation 417   417  
Net loss (3,752)     (3,752)
Ending balance (in shares) at Mar. 31, 2025   17,950,033    
Ending balance at Mar. 31, 2025 $ 6,403 $ 18 304,468 (298,083)
Beginning balance (in shares) at Dec. 31, 2025 22,911,575 22,911,575    
Beginning balance at Dec. 31, 2025 $ 17,449 $ 23 331,708 (314,282)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of stock from cashless warrant exercises (in shares)   804,788    
Issuance of stock from cashless warrant exercises $ 0 $ 1 (1)  
Issuance of stock from vested restricted stock units (in shares)   275,671    
Issuance of stock under Employee Stock Purchase Plan (in shares) 96,023 96,023    
Issuance of stock under Employee Stock Purchase Plan $ 295   295  
Stock-based compensation 655   655  
Net loss $ (3,967)     (3,967)
Ending balance (in shares) at Mar. 31, 2026 24,088,057 24,088,057    
Ending balance at Mar. 31, 2026 $ 14,432 $ 24 $ 332,657 $ (318,249)